Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Live Notes, Real Time Conference Coverage 2020 AACR Virtual Meeting April 28, 2020 Session on NCI Activities: COVID-19 and Cancer Research 5:20 PM

Reporter: Stephen J. Williams, PhD

NCI Activities: COVID-19 and Cancer Research

Dinah S. Singer. NCI-DCB, Bethesda, MD @theNCI

• at the NCI they are pivoting some of their clinical trials to address COVID related issues like trials on tocilizumab and producing longitudinal cohorts of cancer patients and COVID for further analysis and studies
• vaccine and antibody efforts at NCI and they are asking all their cancer centers (Cancer COVID Consortium) collecting data
• Moonshot is collecting metadata but now COVID data from cellular therapy patients
• they are about to publish new grants related to COVID and adding option to investigators to use current funds to do COVID related options
• she says if at home take the time to think, write manuscripts, analyze data BE A REVIEWER FOR JOURNALS,
• SSMMART project from Moonshot is still active
• so far NCI and NIH grant process is ongoing although the peer review process is slower
• they have extended deadlines with NO justification required (extend 90 days)
• also allowing flexibility on use of grant money and allowing more early investigator rules and lax on those rules
• non competitive renewals (type 5) will allow restructuring of project; contact program administrator
• she and NCI heard rumors of institutions shutting down cancer research she is stressing to them not to do that
• non refundable travel costs may be charged to the grant
• NCI contemplating on extending the early investigator time
• for more information go to NIH and NCI COVID-19 pages which have more guidances updated regularly

Follow on Twitter at:

@pharma_BI

@AACR

@CureCancerNow

@pharmanews

@BiotechWorld

@theNCI

#AACR20